Dr. Nick Oberheiden of Oberheiden P.C. has been named a Go-To Thought Leader for his coverage of the US federal government’s various actions related to healthcare fraud. Dr. Oberheiden provided valuable insight into the federal government’s new enforcement effort into amniotic fluid injections, detailing how the treatment may be subject to investigation for fraud and scientific legitimacy by CMS and the US Department of Justice and saw considerable readership throughout the year.
Dr. Nick Oberheiden is a Go-To Thought Leader for 2021 for his coverage of FDA investigations. NLR readers turn to Dr. Oberheiden’s experience conducting internal investigations and leading defense teams in whistleblower cases. Of particular note are Dr. Oberheiden’s articles on what to expect when facing an investigation by a government agency like the FDA, outlining practical information and strategies readers can use.
The National Law Review named Dr. Nick Oberheiden of Oberheiden P.C as a Go-To Thought Leader for his ‘what to do’ advice related to federal target letters, FBI Subpoenas, Administrative Law Judge hearings and healthcare fraud investigations. Dr. Oberheiden’s experience conducting internal corporate investigations and leading defense teams in a variety of actions, including whistleblower and corporate defense cases really shows in his writing. Dr. Oberheiden also analyzes trends in federal enforcement including personal protection equipment fraud, pharmacy compliance and fraud issues, and the newly emerging area of Paycheck Protection Program Fraud.
